Skip to main content
. 2013 Dec 27;8(12):e83699. doi: 10.1371/journal.pone.0083699

Figure 9. The effects of combined SIL and DAPT on HepG2 tumor xenografts in vivo.

Figure 9

Photographs showing tumor xenograft morphologiesinthe different groups. B. A tumor growth curve was drawn from the tumor volumes and the treatment duration. C. Representative Western blot results are shown. The results are expressed as the means ± SEM, n = 6. aP<0.05, compared with the control group; aaP<0.01, compared with the control group; bbP<0.01, compared with the SIL 400 mg/kg group; ccP<0.01, compared with the DAPT+SIL 400 mg/kg group. SIL, silybin.